Do analysts rate AVD or CBUS?

Cibus has a consensus price target of $9.00, indicating a potential upside of 397.24%. Given Cibus' stronger consensus rating and higher possible upside, analysts clearly believe Cibus is more favorable than American Vanguard. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cibus 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation & earnings, AVD or CBUS?

American Vanguard has higher revenue and earnings than Cibus. American Vanguard is trading at a lower price-to-earnings ratio than Cibus, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio American Vanguard $515.11M 0.13 -$49.88M -$1.59 N/A Cibus $3.64M 37.96 -$127.08M -$1.97 N/A

Is AVD or CBUS more profitable?

American Vanguard has a net margin of -8.71% compared to Cibus' net margin of -2,366.33%. American Vanguard's return on equity of -4.13% beat Cibus' return on equity. Company Net Margins Return on Equity Return on Assets American Vanguard -8.71% -4.13% -1.34% Cibus -2,366.33% -200.87% -28.28%

Do analysts rate BIOX or AVD?

Bioceres Crop Solutions presently has a consensus price target of $4.00, suggesting a potential upside of 1,061.78%. Given Bioceres Crop Solutions' stronger consensus rating and higher probable upside, equities analysts plainly believe Bioceres Crop Solutions is more favorable than American Vanguard. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bioceres Crop Solutions 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate AVD or SNES?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Senestech 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts rate CTVA or AVD?

Corteva presently has a consensus price target of $91.70, suggesting a potential upside of 19.17%. Given Corteva's stronger consensus rating and higher probable upside, equities research analysts plainly believe Corteva is more favorable than American Vanguard. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Corteva 0 Sell rating(s) 8 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 2.70 American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, CTVA or AVD?

Corteva has higher revenue and earnings than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than Corteva, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Corteva $17.40B 2.95 $1.09B $1.51 50.96 American Vanguard $515.11M 0.13 -$49.88M -$1.59 N/A

Do analysts recommend AVD or NTR?

Nutrien has a consensus price target of $81.84, indicating a potential upside of 27.10%. Given Nutrien's stronger consensus rating and higher probable upside, analysts plainly believe Nutrien is more favorable than American Vanguard. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Vanguard 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Nutrien 1 Sell rating(s) 3 Hold rating(s) 17 Buy rating(s) 0 Strong Buy rating(s) 2.76

Which has preferable earnings and valuation, AVD or NTR?

Nutrien has higher revenue and earnings than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than Nutrien, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio American Vanguard $515.11M 0.13 -$49.88M -$1.59 N/A Nutrien $26.89B 1.15 $2.27B $4.91 13.11

American Vanguard (AVD) Competitors

$2.42 -0.16 (-6.03%)

Closing price 08/7/2026 03:59 PM Eastern

Extended Trading

$2.42 0.00 (0.00%)

As of 08/7/2026 07:34 PM Eastern

Compare

AVD vs. CBUS, BIOX, SNES, CTVA, and NTR

Should you buy American Vanguard stock or one of its competitors? MarketBeat compares American Vanguard with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with American Vanguard include Cibus (CBUS), Bioceres Crop Solutions (BIOX), Senestech (SNES), Corteva (CTVA), and Nutrien (NTR). These companies are all part of the "fertilizers & agricultural chemicals" industry.

How does American Vanguard compare to Cibus?

American Vanguard (NYSE:AVD) and Cibus (NASDAQ:CBUS) are both small-cap materials companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

79.0% of American Vanguard shares are owned by institutional investors. Comparatively, 33.8% of Cibus shares are owned by institutional investors. 5.6% of American Vanguard shares are owned by company insiders. Comparatively, 29.9% of Cibus shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cibus has a consensus price target of $9.00, indicating a potential upside of 397.24%. Given Cibus' stronger consensus rating and higher possible upside, analysts clearly believe Cibus is more favorable than American Vanguard.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cibus	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

American Vanguard has higher revenue and earnings than Cibus. American Vanguard is trading at a lower price-to-earnings ratio than Cibus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Vanguard	$515.11M	0.13	-$49.88M	-$1.59	N/A
Cibus	$3.64M	37.96	-$127.08M	-$1.97	N/A

In the previous week, Cibus had 2 more articles in the media than American Vanguard. MarketBeat recorded 2 mentions for Cibus and 0 mentions for American Vanguard. American Vanguard's average media sentiment score of 0.00 equaled Cibus'average media sentiment score.

Company	Overall Sentiment
American Vanguard	Neutral
Cibus	Neutral

American Vanguard has a net margin of -8.71% compared to Cibus' net margin of -2,366.33%. American Vanguard's return on equity of -4.13% beat Cibus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Vanguard	-8.71%	-4.13%	-1.34%
Cibus	-2,366.33%	-200.87%	-28.28%

American Vanguard has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market. Comparatively, Cibus has a beta of 1.61, indicating that its share price is 61% more volatile than the broader market.

Summary

Cibus beats American Vanguard on 8 of the 15 factors compared between the two stocks.

How does American Vanguard compare to Bioceres Crop Solutions?

Bioceres Crop Solutions (NASDAQ:BIOX) and American Vanguard (NYSE:AVD) are both small-cap materials companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation.

In the previous week, Bioceres Crop Solutions had 1 more articles in the media than American Vanguard. MarketBeat recorded 1 mentions for Bioceres Crop Solutions and 0 mentions for American Vanguard. Bioceres Crop Solutions' average media sentiment score of 0.44 beat American Vanguard's score of 0.00 indicating that Bioceres Crop Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
Bioceres Crop Solutions	Neutral
American Vanguard	Neutral

17.7% of Bioceres Crop Solutions shares are owned by institutional investors. Comparatively, 79.0% of American Vanguard shares are owned by institutional investors. 2.3% of Bioceres Crop Solutions shares are owned by insiders. Comparatively, 5.6% of American Vanguard shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

American Vanguard has a net margin of -8.71% compared to Bioceres Crop Solutions' net margin of -92.85%. American Vanguard's return on equity of -4.13% beat Bioceres Crop Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioceres Crop Solutions	-92.85%	-33.97%	-10.31%
American Vanguard	-8.71%	-4.13%	-1.34%

American Vanguard has higher revenue and earnings than Bioceres Crop Solutions. American Vanguard is trading at a lower price-to-earnings ratio than Bioceres Crop Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioceres Crop Solutions	$293.67M	0.07	-$55.42M	-$3.86	N/A
American Vanguard	$515.11M	0.13	-$49.88M	-$1.59	N/A

Bioceres Crop Solutions presently has a consensus price target of $4.00, suggesting a potential upside of 1,061.78%. Given Bioceres Crop Solutions' stronger consensus rating and higher probable upside, equities analysts plainly believe Bioceres Crop Solutions is more favorable than American Vanguard.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bioceres Crop Solutions	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Bioceres Crop Solutions has a beta of 0.41, suggesting that its share price is 59% less volatile than the broader market. Comparatively, American Vanguard has a beta of 1.43, suggesting that its share price is 43% more volatile than the broader market.

Summary

American Vanguard beats Bioceres Crop Solutions on 10 of the 16 factors compared between the two stocks.

How does American Vanguard compare to Senestech?

American Vanguard (NYSE:AVD) and Senestech (NASDAQ:SNES) are both small-cap materials companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.

79.0% of American Vanguard shares are held by institutional investors. Comparatively, 5.2% of Senestech shares are held by institutional investors. 5.6% of American Vanguard shares are held by company insiders. Comparatively, 2.2% of Senestech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

American Vanguard has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market. Comparatively, Senestech has a beta of 0.28, indicating that its share price is 72% less volatile than the broader market.

Senestech has lower revenue, but higher earnings than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than Senestech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Vanguard	$515.11M	0.13	-$49.88M	-$1.59	N/A
Senestech	$2.22M	3.08	-$6.38M	-$1.89	N/A

In the previous week, Senestech had 6 more articles in the media than American Vanguard. MarketBeat recorded 6 mentions for Senestech and 0 mentions for American Vanguard. Senestech's average media sentiment score of 0.50 beat American Vanguard's score of 0.00 indicating that Senestech is being referred to more favorably in the news media.

Company	Overall Sentiment
American Vanguard	Neutral
Senestech	Positive

American Vanguard has a net margin of -8.71% compared to Senestech's net margin of -294.73%. American Vanguard's return on equity of -4.13% beat Senestech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Vanguard	-8.71%	-4.13%	-1.34%
Senestech	-294.73%	-65.32%	-48.51%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Senestech	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

American Vanguard beats Senestech on 8 of the 14 factors compared between the two stocks.

How does American Vanguard compare to Corteva?

Corteva (NYSE:CTVA) and American Vanguard (NYSE:AVD) are both materials companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and dividends.

Corteva has higher revenue and earnings than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than Corteva, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Corteva	$17.40B	2.95	$1.09B	$1.51	50.96
American Vanguard	$515.11M	0.13	-$49.88M	-$1.59	N/A

In the previous week, Corteva had 20 more articles in the media than American Vanguard. MarketBeat recorded 20 mentions for Corteva and 0 mentions for American Vanguard. Corteva's average media sentiment score of 0.94 beat American Vanguard's score of 0.00 indicating that Corteva is being referred to more favorably in the media.

Company	Overall Sentiment
Corteva	Positive
American Vanguard	Neutral

Corteva has a net margin of 5.66% compared to American Vanguard's net margin of -8.71%. Corteva's return on equity of 10.18% beat American Vanguard's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Corteva	5.66%	10.18%	6.00%
American Vanguard	-8.71%	-4.13%	-1.34%

Corteva has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market. Comparatively, American Vanguard has a beta of 1.43, meaning that its stock price is 43% more volatile than the broader market.

Corteva presently has a consensus price target of $91.70, suggesting a potential upside of 19.17%. Given Corteva's stronger consensus rating and higher probable upside, equities research analysts plainly believe Corteva is more favorable than American Vanguard.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Corteva	0 Sell rating(s)	8 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.70
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

81.5% of Corteva shares are owned by institutional investors. Comparatively, 79.0% of American Vanguard shares are owned by institutional investors. 0.2% of Corteva shares are owned by company insiders. Comparatively, 5.6% of American Vanguard shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Corteva beats American Vanguard on 15 of the 17 factors compared between the two stocks.

How does American Vanguard compare to Nutrien?

American Vanguard (NYSE:AVD) and Nutrien (NYSE:NTR) are both materials companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

79.0% of American Vanguard shares are held by institutional investors. Comparatively, 63.1% of Nutrien shares are held by institutional investors. 5.6% of American Vanguard shares are held by insiders. Comparatively, 3.1% of Nutrien shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

American Vanguard has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market. Comparatively, Nutrien has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market.

Nutrien has a consensus price target of $81.84, indicating a potential upside of 27.10%. Given Nutrien's stronger consensus rating and higher probable upside, analysts plainly believe Nutrien is more favorable than American Vanguard.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Vanguard	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Nutrien	1 Sell rating(s)	3 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.76

In the previous week, Nutrien had 23 more articles in the media than American Vanguard. MarketBeat recorded 23 mentions for Nutrien and 0 mentions for American Vanguard. Nutrien's average media sentiment score of 0.67 beat American Vanguard's score of 0.00 indicating that Nutrien is being referred to more favorably in the news media.

Company	Overall Sentiment
American Vanguard	Neutral
Nutrien	Positive

Nutrien has a net margin of 8.44% compared to American Vanguard's net margin of -8.71%. Nutrien's return on equity of 8.88% beat American Vanguard's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Vanguard	-8.71%	-4.13%	-1.34%
Nutrien	8.44%	8.88%	4.27%

Nutrien has higher revenue and earnings than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than Nutrien, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Vanguard	$515.11M	0.13	-$49.88M	-$1.59	N/A
Nutrien	$26.89B	1.15	$2.27B	$4.91	13.11

Summary

Nutrien beats American Vanguard on 13 of the 16 factors compared between the two stocks.

Get American Vanguard News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVD vs. The Competition

Export

Metric	American Vanguard	Chemicals Industry	Materials Sector	NYSE Exchange
Market Cap	$73.52M	$11.38B	$4.85B	$24.09B
Dividend Yield	N/A	2.81%	4.72%	3.71%
P/E Ratio	-1.52	20.80	21.05	29.18
Price / Sales	0.13	47.50	5,293.02	18.31
Price / Cash	5.59	15.50	26.83	32.96
Price / Book	0.36	3.48	8.74	6.87
Net Income	-$49.88M	$223.51M	$154.73M	$1.06B
7 Day Performance	1.34%	2.85%	7.32%	2.90%
1 Month Performance	-6.94%	3.56%	6.23%	3.42%
1 Year Performance	-48.18%	22.62%	43.45%	20.29%

American Vanguard Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVD American Vanguard	1.429 of 5 stars	$2.42 -6.0%	N/A	-46.8%	$73.52M	$515.11M	N/A	800
CBUS Cibus	1.4984 of 5 stars	$1.89 -2.1%	$9.00 +376.2%	+22.7%	$147.32M	$3.64M	N/A	48	News Coverage Upcoming Earnings
BIOX Bioceres Crop Solutions	1.8293 of 5 stars	$0.37 +2.6%	$4.00 +983.1%	-89.6%	$22.76M	$333.30M	N/A	500	Gap Up
SNES Senestech	2.2385 of 5 stars	$1.55 +14.8%	N/A	-76.1%	$7.16M	$2.22M	N/A	30	News Coverage Positive News Earnings Report High Trading Volume
CTVA Corteva	4.3771 of 5 stars	$76.03 -3.4%	$91.38 +20.2%	+8.4%	$52.64B	$17.40B	50.35	21,500	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AVD) was last updated on 8/8/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

American Vanguard (AVD) Competitors

AVD vs. CBUS, BIOX, SNES, CTVA, and NTR

How does American Vanguard compare to Cibus?

Summary

How does American Vanguard compare to Bioceres Crop Solutions?

Summary

How does American Vanguard compare to Senestech?

Summary

How does American Vanguard compare to Corteva?

Summary

How does American Vanguard compare to Nutrien?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVD vs. The Competition

American Vanguard Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

American Vanguard (AVD) Competitors

AVD vs. CBUS, BIOX, SNES, CTVA, and NTR

How does American Vanguard compare to Cibus?

Do insiders and institutionals have more ownership in AVD or CBUS?

Do analysts rate AVD or CBUS?

Which has preferable valuation & earnings, AVD or CBUS?

Does the media refer more to AVD or CBUS?

Is AVD or CBUS more profitable?

Which has more volatility & risk, AVD or CBUS?

Summary

How does American Vanguard compare to Bioceres Crop Solutions?

Does the media prefer BIOX or AVD?

Do insiders & institutionals hold more shares of BIOX or AVD?

Is BIOX or AVD more profitable?

Which has preferable earnings & valuation, BIOX or AVD?

Do analysts rate BIOX or AVD?

Which has more volatility and risk, BIOX or AVD?

Summary

How does American Vanguard compare to Senestech?

Do institutionals & insiders believe in AVD or SNES?

Which has more risk and volatility, AVD or SNES?

Which has preferable valuation and earnings, AVD or SNES?

Does the media refer more to AVD or SNES?

Is AVD or SNES more profitable?

Do analysts rate AVD or SNES?

Summary

How does American Vanguard compare to Corteva?

Which has better earnings and valuation, CTVA or AVD?

Does the media favor CTVA or AVD?

Is CTVA or AVD more profitable?

Which has more risk and volatility, CTVA or AVD?

Do analysts rate CTVA or AVD?

Do institutionals & insiders hold more shares of CTVA or AVD?

Summary

How does American Vanguard compare to Nutrien?

Do insiders and institutionals have more ownership in AVD or NTR?

Which has more risk & volatility, AVD or NTR?

Do analysts recommend AVD or NTR?

Does the media favor AVD or NTR?

Is AVD or NTR more profitable?

Which has preferable earnings and valuation, AVD or NTR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVD vs. The Competition

American Vanguard Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools